Reach out and one of our experts will help with your slot-die coating requirements

Investor

Select language version:

Calender

Events and financial calender

Speaker

Announcements and financial reports

Share and investor portal

Legal

Legal documents

Paper

Commissioned research

On this site, we have gathered all information, relevant for current and potential investors. We hope that you’d like to join our growth journey!

MLMC Therapeutics is a subsidary of FOM Technologies.

Our mission is to develop production processes for oral drugs. At present the company has no operational activity.

FOM Technologies owns a 51% stake in MLMC Therapeutics ApS.